Creative Medical Technology Holdings, Inc. Management Fee Payable
Creative Medical Technology Holdings, Inc. (CELZ) had Management Fee Payable of $0 as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Balance Sheet › Liabilities
us-gaap:ManagementFeePayable · last filed 2023-03-31
- 2022-12-31: Management Fee Payable $0.00.
- 2022-09-30: Management Fee Payable $0.00.
- 2022-06-30: Management Fee Payable $0.00.
- 2022-03-31: Management Fee Payable $0.00.
| Period end | Management Fee Payable |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 |
| 2021-12-31 | $250.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $250.08K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $302.58K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $255.08K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $468.78K 10-K · filed 2022-03-30 |
| 2020-09-30 | $211.28K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $240.28K 10-Q · filed 2020-08-14 |
| 2019-12-31 | $240.08K 10-K · filed 2021-03-17 |
| 2019-09-30 | $53.08K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $118.08K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $153.08K 10-Q · filed 2019-05-20 |
| 2018-12-31 | $198.08K 10-Q · filed 2019-11-14 |
| 2018-09-30 | $269.05K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $254.05K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $397.00K 10-Q · filed 2018-08-03 |
| 2017-12-31 | $352.75K 10-K · filed 2019-04-01 |
| 2017-09-30 | $310.50K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $293.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $262.50K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $280.00K 10-K · filed 2018-03-29 |
| 2016-09-30 | $280.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $210.00K 10-Q · filed 2016-08-19 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |